Amarin Pharma Inc. v. International Trade Commission
Petition for certiorari denied on December 9, 2019
Issue: Whether, when a manufacturer files a Lanham Act claim under the Tariff Act for competitive injuries caused by unfair trade practices, the claim is barred as a matter of law when the International Trade Commission would need to consider the meaning of terms used in the Food, Drug and Cosmetic Act in order to determine whether the claim has merit.
SCOTUSblog Coverage
- Petitions of the week (Andrew Hamm, September 3, 2019)
Date | Proceedings and Orders |
---|---|
07/30/2019 | Petition for a writ of certiorari filed. (Response due September 3, 2019) |
08/27/2019 | Motion of International Trade Commission, et al. for an extension of time not accepted for filing. (August 28, 2019 - Corrected motion to be filed) |
08/28/2019 | Motion to extend the time to file a response from September 3, 2019 to October 3, 2019, submitted to The Clerk. |
08/30/2019 | Motion to extend the time to file a response is granted and the time is extended to and including October 3, 2019, for all respondents. |
09/30/2019 | Motion to extend the time to file a response from October 3, 2019 to November 4, 2019, submitted to The Clerk. |
10/02/2019 | Motion to extend the time to file a response is granted and the time is further extended to and including November 4, 2019, for all respondents. |
10/22/2019 | Letter of October 22, 2019 from counsel for petitioners filed. |
11/04/2019 | Brief of respondents International Trade Commission, et al. in opposition filed. |
11/04/2019 | Brief of respondents Royal DSM NV, et al. in opposition filed. |
11/18/2019 | Reply of petitioners Amarin Pharma, Inc., et al. filed. |
11/20/2019 | DISTRIBUTED for Conference of 12/6/2019. |
12/09/2019 | Petition DENIED. |